DNA repair-deficient tumours are eligible for effective targeted therapies, but reliable diagnostic strategies based on functional assays are needed. Here the authors develop methods for the rapid assessment of homologous recombination and mismatch repair status in tumor tissues, allowing drug efficacy to be predicted.
- Shinta Saito
- Shingo Kato
- Noritaka Adachi
